Related Experiment Video
Updated: Aug 19, 2026

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults
Published on: July 16, 2016
[Sweet's syndrome in a child]
1Service de Dermatologie, CHU Mohammed VI, Marrakech, Maroc. karima_doc@hotmail.com
Insights
Sweet's syndrome, a rare pediatric condition, can manifest in infants. Early corticosteroid treatment shows promise for managing this inflammatory disorder.
Area of Science:
- Pediatric Dermatology
- Hematology
- Immunology
Background:
- Sweet's syndrome, first described in 1964, is predominantly diagnosed in adults.
- Its occurrence in pediatric populations, particularly infants, is exceptionally rare.
Observation:
- A 23-month-old boy presented with characteristic skin lesions including papular, edematous annular plaques with surrounding vesicles and bullae.
- Initial laboratory findings revealed neutrophilic hyperleukocytosis, anemia, and an inflammatory syndrome.
Findings:
- The patient showed a significant clinical response to oral corticosteroids at a dosage of 2 mg/kg/d.
- Despite initial improvement, the infant later developed cervical adenopathies and hepatomegaly, with subsequent myelograms remaining normal.
Implications:
- This case highlights the rarity of Sweet's syndrome in infants and the importance of considering hematologic malignancies.
- Systemic corticosteroid therapy is established as the primary treatment modality for Sweet's syndrome.
Introduction:
Sweet's syndrome was described for the first time in 1964. It is usually described in adults and remains rare in children. We report a case in a 23 month-old infant.
Observation:
A 23 month-old boy presented with diffuse papular, edematous annular plaques surrounded by vesicles and bullas. Laboratory examinations revealed neutrophilic polynuclear hyperleukocytosis, anemia and an inflammatory syndrome. The myelogram was rich and the abdominal sonography normal. Oral corticosteroids (2 mg/kg/d) led to spectacular improvement. After 19 days' treatment, the boy developed cervical adenopathies and hepatomegaly. The second myelogram was normal. Evolution under corticosteroids was good.
Discussion:
Sweet's syndrome is exceptional in infants. The frequent association with a malignant blood disease should prompt appropriate investigations and prolonged surveillance. Systemic corticosteroid therapy is the reference.
More Related Videos
08:52Psychophysical Tracking Method to Assess Taste Detection Thresholds in Children, Adolescents, and Adults: The Taste Detection Threshold (TDT) Test
Published on: April 21, 2021
11:16A Novel Procedure for Evaluating the Reinforcing Properties of Tastants in Laboratory Rats: Operant Intraoral Self-administration
Published on: February 6, 2014
Related Concept Videos
The Physiology of Taste
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hyperosmolar Hyperglycemic State
Inborn Errors of Metabolism
Conditioned Taste Aversion
A notable characteristic of conditioned taste aversion is that it often requires only a single exposure...